TMEM16A is also known as ANO1, DOG1, TAOS2, and ORAOV2, because it was known to be amplified and overexpressed in cancers before it was identified as a CaCCs with eight putative transmembrane domains and N- and C-termini oriented towards the cytoplasm [9,10,11]. The gene discussed is ANO1; the disease is cancer.